BUY Divi's Laboratories — Chandan Taparia, 24 Sept 2026

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))24 Sept 2026via LiveMint Buy-or-Sell (topic)

Entry₹9,602Inferred

Target₹10,000

Stop loss₹9,400-2.10% risk

CMP₹9,577.5Just now

Active-0.26%+4.41%upside left 14d left

Follow Chandan Taparia for new calls(33% target hit, 198 closed calls)Get alerts Watch DIVISLAB for new buy/sell callsGet alerts See 1 other Swing call on DIVISLAB See 268 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Sept, 2:18 pm IST

3 supporting2 neutral1 opposing

Supports the BUY call (3)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·23 Sept · yesterday

Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth

NewsGoogle News·15 Sept · 1w ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·26 Aug · 4w ago

Neutral / worth noting (2)

Divi's Laboratories (DIVISLAB.NS) Steadies Near ₹9,410 as Pharma Major Holds Above Key Support - Catalyst Driven Stocks

NewsGoogle News·22 Sept · 3d ago

2 quiet pharma stocks are making very different cash bets. Add to watchlist?

NewsGoogle News·15 Sept · 1w ago

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·25 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Divi's Laboratories Limited — Chandan Taparia, Motilal Oswal

AI Assessment